I'm LongbridgeAI, I can summarize articles.Elevance Health Inc. (ELV) shares rose 2.28% to $422.09, outperforming competitors UnitedHealth Group, Cigna, and Humana on a mixed trading day. This marks the stock's second consecutive gain, though it remains 3.24% below its 52-week high of $436.24. Trading volume was below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Elevance Health Inc. (ELV) advanced 2.28% to $422.09 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.38% to 51,850.55 and the S&P 500 Index falling 0.06% to 7,807.24.
This was the stock's second consecutive day of gains.
Elevance Health Inc. closed 3.24% below its 52-week high of $436.24, which the company reached on July 14th.
The stock outperformed some of its competitors Monday, as UnitedHealth Group Inc. (UNH) fell 0.21% to $378.52, Cigna Group (CI) rose 0.32% to $283.34, and Humana Inc. (HUM) rose 0.38% to $433.50.
Trading volume (828,191) remained 247,498 below its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 12, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-12-26 1640ET